 | • レポートコード：GIR201102493 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、凝固因子濃縮物の世界市場を調査対象にし、凝固因子濃縮物の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（第VIII因子、第IX因子、フォンヴィレブランド因子、プロトロンビン複合濃縮物、フィブリノーゲン濃縮物、第XIII因子）、用途別分析（神経、免疫、血液、クリティカルケア、呼吸器、血液腫瘍、リウマチ、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：CSL (Australia)、LFB (France)、Octapharma (Switzerland)、Grifols (Spain)、Sanquin (Netherlands)、Shire (Ireland)、Japan Blood Products Organization, China Biologic Products (China)、Bio Product Laboratory (UK)、Kedrion (Italy)、Biotest (Germany)、Green Cross Corporation (South Korea)、Shanghai RAAS Blood Products (China) ・メーカー別販売量、売上、市場シェア ・凝固因子濃縮物の地域別市場分析 ・凝固因子濃縮物の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・凝固因子濃縮物のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・凝固因子濃縮物のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・凝固因子濃縮物の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・凝固因子濃縮物の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・凝固因子濃縮物の種類別市場規模2015-2020：第VIII因子、第IX因子、フォンヴィレブランド因子、プロトロンビン複合濃縮物、フィブリノーゲン濃縮物、第XIII因子 ・凝固因子濃縮物の用途別市場規模2015-2020：神経、免疫、血液、クリティカルケア、呼吸器、血液腫瘍、リウマチ、その他 ・凝固因子濃縮物の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Coagulation Factor Concentrates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Coagulation Factor Concentrates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Coagulation Factor Concentrates market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Coagulation Factor Concentrates market has been segmented into
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrates
Fibrinogen Concentrates
Factor XIII
By Application, Coagulation Factor Concentrates has been segmented into:
Neurology
Immunology
Hematology
Critical Care
Pulmonology
Hemato-Oncology
Rheumatology
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Coagulation Factor Concentrates market presented in the report. This section sheds light on the sales growth of different regional and country-level Coagulation Factor Concentrates markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Coagulation Factor Concentrates market.
The report offers in-depth assessment of the growth and other aspects of the Coagulation Factor Concentrates market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Coagulation Factor Concentrates Market Share Analysis
Coagulation Factor Concentrates competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Coagulation Factor Concentrates sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Coagulation Factor Concentrates sales, revenue and market share for each player covered in this report.
The major players covered in Coagulation Factor Concentrates are:
CSL (Australia)
LFB (France)
Octapharma (Switzerland)
Grifols (Spain)
Sanquin (Netherlands)
Shire (Ireland)
Japan Blood Products Organization, China Biologic Products (China)
Bio Product Laboratory (UK)
Kedrion (Italy)
Biotest (Germany)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China)
Among other players domestic and global, Coagulation Factor Concentrates market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Coagulation Factor Concentrates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Coagulation Factor Concentrates, with price, sales, revenue and global market share of Coagulation Factor Concentrates in 2018 and 2019.
Chapter 3, the Coagulation Factor Concentrates competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coagulation Factor Concentrates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Coagulation Factor Concentrates market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Coagulation Factor Concentrates sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Coagulation Factor Concentrates Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Coagulation Factor Concentrates Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Factor VIII
1.2.3 Factor IX
1.2.4 Von Willebrand Factor
1.2.5 Prothrombin Complex Concentrates
1.2.6 Fibrinogen Concentrates
1.2.7 Factor XIII
1.3 Market Analysis by Application
1.3.1 Overview: Global Coagulation Factor Concentrates Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Neurology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Critical Care
1.3.6 Pulmonology
1.3.7 Hemato-Oncology
1.3.8 Rheumatology
1.3.9 Others
1.4 Overview of Global Coagulation Factor Concentrates Market
1.4.1 Global Coagulation Factor Concentrates Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL (Australia)
2.1.1 CSL (Australia) Details
2.1.2 CSL (Australia) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL (Australia) SWOT Analysis
2.1.4 CSL (Australia) Product and Services
2.1.5 CSL (Australia) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 LFB (France)
2.2.1 LFB (France) Details
2.2.2 LFB (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 LFB (France) SWOT Analysis
2.2.4 LFB (France) Product and Services
2.2.5 LFB (France) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Octapharma (Switzerland)
2.3.1 Octapharma (Switzerland) Details
2.3.2 Octapharma (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Octapharma (Switzerland) SWOT Analysis
2.3.4 Octapharma (Switzerland) Product and Services
2.3.5 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grifols (Spain)
2.4.1 Grifols (Spain) Details
2.4.2 Grifols (Spain) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grifols (Spain) SWOT Analysis
2.4.4 Grifols (Spain) Product and Services
2.4.5 Grifols (Spain) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanquin (Netherlands)
2.5.1 Sanquin (Netherlands) Details
2.5.2 Sanquin (Netherlands) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanquin (Netherlands) SWOT Analysis
2.5.4 Sanquin (Netherlands) Product and Services
2.5.5 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Shire (Ireland)
2.6.1 Shire (Ireland) Details
2.6.2 Shire (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Shire (Ireland) SWOT Analysis
2.6.4 Shire (Ireland) Product and Services
2.6.5 Shire (Ireland) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Japan Blood Products Organization, China Biologic Products (China)
2.7.1 Japan Blood Products Organization, China Biologic Products (China) Details
2.7.2 Japan Blood Products Organization, China Biologic Products (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Japan Blood Products Organization, China Biologic Products (China) SWOT Analysis
2.7.4 Japan Blood Products Organization, China Biologic Products (China) Product and Services
2.7.5 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio Product Laboratory (UK)
2.8.1 Bio Product Laboratory (UK) Details
2.8.2 Bio Product Laboratory (UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio Product Laboratory (UK) SWOT Analysis
2.8.4 Bio Product Laboratory (UK) Product and Services
2.8.5 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Kedrion (Italy)
2.9.1 Kedrion (Italy) Details
2.9.2 Kedrion (Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Kedrion (Italy) SWOT Analysis
2.9.4 Kedrion (Italy) Product and Services
2.9.5 Kedrion (Italy) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biotest (Germany)
2.10.1 Biotest (Germany) Details
2.10.2 Biotest (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biotest (Germany) SWOT Analysis
2.10.4 Biotest (Germany) Product and Services
2.10.5 Biotest (Germany) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Green Cross Corporation (South Korea)
2.11.1 Green Cross Corporation (South Korea) Details
2.11.2 Green Cross Corporation (South Korea) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Green Cross Corporation (South Korea) SWOT Analysis
2.11.4 Green Cross Corporation (South Korea) Product and Services
2.11.5 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Shanghai RAAS Blood Products (China)
2.12.1 Shanghai RAAS Blood Products (China) Details
2.12.2 Shanghai RAAS Blood Products (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Shanghai RAAS Blood Products (China) SWOT Analysis
2.12.4 Shanghai RAAS Blood Products (China) Product and Services
2.12.5 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Coagulation Factor Concentrates Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Coagulation Factor Concentrates Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Coagulation Factor Concentrates Manufacturer Market Share in 2019
3.3.2 Top 6 Coagulation Factor Concentrates Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Coagulation Factor Concentrates Sales, Revenue and Market Share by Regions
4.1.1 Global Coagulation Factor Concentrates Sales and Market Share by Regions (2015-2020)
4.1.2 Global Coagulation Factor Concentrates Revenue and Market Share by Regions (2015-2020)
4.2 North America Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
4.3 Europe Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
4.5 South America Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Coagulation Factor Concentrates Sales, Revenue and Market Share by Country
5.1.1 North America Coagulation Factor Concentrates Sales and Market Share by Country (2015-2020)
5.1.2 North America Coagulation Factor Concentrates Revenue and Market Share by Country (2015-2020)
5.2 United States Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
5.3 Canada Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
5.4 Mexico Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Coagulation Factor Concentrates Sales, Revenue and Market Share by Country
6.1.1 Europe Coagulation Factor Concentrates Sales and Market Share by Country (2015-2020)
6.1.2 Europe Coagulation Factor Concentrates Revenue and Market Share by Country (2015-2020)
6.2 Germany Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
6.3 UK Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
6.4 France Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
6.5 Russia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
6.6 Italy Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Coagulation Factor Concentrates Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Coagulation Factor Concentrates Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Coagulation Factor Concentrates Revenue and Market Share by Regions (2015-2020)
7.2 China Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7.3 Japan Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7.4 Korea Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7.5 India Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
7.7 Australia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Coagulation Factor Concentrates Sales, Revenue and Market Share by Country
8.1.1 South America Coagulation Factor Concentrates Sales and Market Share by Country (2015-2020)
8.1.2 South America Coagulation Factor Concentrates Revenue and Market Share by Country (2015-2020)
8.2 Brazil Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
8.3 Argentina Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Coagulation Factor Concentrates Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Coagulation Factor Concentrates Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Coagulation Factor Concentrates Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
9.3 Turkey Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
9.4 Egypt Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
9.5 South Africa Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Coagulation Factor Concentrates Sales and Market Share by Type (2015-2020)
10.2 Global Coagulation Factor Concentrates Revenue and Market Share by Type (2015-2020)
10.3 Global Coagulation Factor Concentrates Price by Type (2015-2020)
11 Global Coagulation Factor Concentrates Market Segment by Application
11.1 Global Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
11.2 Global Coagulation Factor Concentrates Revenue Market Share by Application (2015-2020)
11.3 Global Coagulation Factor Concentrates Price by Application (2015-2020)
12 Market Forecast
12.1 Global Coagulation Factor Concentrates Sales, Revenue and Growth Rate (2021-2025)
12.2 Coagulation Factor Concentrates Market Forecast by Regions (2021-2025)
12.2.1 North America Coagulation Factor Concentrates Market Forecast (2021-2025)
12.2.2 Europe Coagulation Factor Concentrates Market Forecast (2021-2025)
12.2.3 Asia-Pacific Coagulation Factor Concentrates Market Forecast (2021-2025)
12.2.4 South America Coagulation Factor Concentrates Market Forecast (2021-2025)
12.2.5 Middle East & Africa Coagulation Factor Concentrates Market Forecast (2021-2025)
12.3 Coagulation Factor Concentrates Market Forecast by Type (2021-2025)
12.3.1 Global Coagulation Factor Concentrates Sales Forecast by Type (2021-2025)
12.3.2 Global Coagulation Factor Concentrates Market Share Forecast by Type (2021-2025)
12.4 Coagulation Factor Concentrates Market Forecast by Application (2021-2025)
12.4.1 Global Coagulation Factor Concentrates Sales Forecast by Application (2021-2025)
12.4.2 Global Coagulation Factor Concentrates Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Coagulation Factor Concentrates Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Coagulation Factor Concentrates Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. CSL (Australia) Basic Information, Manufacturing Base and Competitors
Table 8. CSL (Australia) Coagulation Factor Concentrates Major Business
Table 9. CSL (Australia) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 10. CSL (Australia) SWOT Analysis
Table 11. CSL (Australia) Coagulation Factor Concentrates Product and Services
Table 12. CSL (Australia) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. LFB (France) Basic Information, Manufacturing Base and Competitors
Table 14. LFB (France) Coagulation Factor Concentrates Major Business
Table 15. LFB (France) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 16. LFB (France) SWOT Analysis
Table 17. LFB (France) Coagulation Factor Concentrates Product and Services
Table 18. LFB (France) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Octapharma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 20. Octapharma (Switzerland) Coagulation Factor Concentrates Major Business
Table 21. Octapharma (Switzerland) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 22. Octapharma (Switzerland) SWOT Analysis
Table 23. Octapharma (Switzerland) Coagulation Factor Concentrates Product and Services
Table 24. Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Grifols (Spain) Basic Information, Manufacturing Base and Competitors
Table 26. Grifols (Spain) Coagulation Factor Concentrates Major Business
Table 27. Grifols (Spain) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 28. Grifols (Spain) SWOT Analysis
Table 29. Grifols (Spain) Coagulation Factor Concentrates Product and Services
Table 30. Grifols (Spain) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanquin (Netherlands) Basic Information, Manufacturing Base and Competitors
Table 32. Sanquin (Netherlands) Coagulation Factor Concentrates Major Business
Table 33. Sanquin (Netherlands) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 34. Sanquin (Netherlands) SWOT Analysis
Table 35. Sanquin (Netherlands) Coagulation Factor Concentrates Product and Services
Table 36. Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Shire (Ireland) Basic Information, Manufacturing Base and Competitors
Table 38. Shire (Ireland) Coagulation Factor Concentrates Major Business
Table 39. Shire (Ireland) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 40. Shire (Ireland) SWOT Analysis
Table 41. Shire (Ireland) Coagulation Factor Concentrates Product and Services
Table 42. Shire (Ireland) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Japan Blood Products Organization, China Biologic Products (China) Basic Information, Manufacturing Base and Competitors
Table 44. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Major Business
Table 45. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 46. Japan Blood Products Organization, China Biologic Products (China) SWOT Analysis
Table 47. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product and Services
Table 48. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bio Product Laboratory (UK) Basic Information, Manufacturing Base and Competitors
Table 50. Bio Product Laboratory (UK) Coagulation Factor Concentrates Major Business
Table 51. Bio Product Laboratory (UK) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 52. Bio Product Laboratory (UK) SWOT Analysis
Table 53. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product and Services
Table 54. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Kedrion (Italy) Basic Information, Manufacturing Base and Competitors
Table 56. Kedrion (Italy) Coagulation Factor Concentrates Major Business
Table 57. Kedrion (Italy) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 58. Kedrion (Italy) SWOT Analysis
Table 59. Kedrion (Italy) Coagulation Factor Concentrates Product and Services
Table 60. Kedrion (Italy) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Biotest (Germany) Basic Information, Manufacturing Base and Competitors
Table 62. Biotest (Germany) Coagulation Factor Concentrates Major Business
Table 63. Biotest (Germany) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 64. Biotest (Germany) SWOT Analysis
Table 65. Biotest (Germany) Coagulation Factor Concentrates Product and Services
Table 66. Biotest (Germany) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Green Cross Corporation (South Korea) Basic Information, Manufacturing Base and Competitors
Table 68. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Major Business
Table 69. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 70. Green Cross Corporation (South Korea) SWOT Analysis
Table 71. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product and Services
Table 72. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Shanghai RAAS Blood Products (China) Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Major Business
Table 75. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Total Revenue (USD Million) (2018-2019)
Table 76. Shanghai RAAS Blood Products (China) SWOT Analysis
Table 77. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product and Services
Table 78. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Coagulation Factor Concentrates Sales by Manufacturer (2018-2019) (K Pcs)
Table 80. Global Coagulation Factor Concentrates Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Coagulation Factor Concentrates Sales by Regions (2015-2020) (K Pcs)
Table 82. Global Coagulation Factor Concentrates Sales Market Share by Regions (2015-2020)
Table 83. Global Coagulation Factor Concentrates Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Coagulation Factor Concentrates Sales by Countries (2015-2020) (K Pcs)
Table 85. North America Coagulation Factor Concentrates Sales Market Share by Countries (2015-2020)
Table 86. North America Coagulation Factor Concentrates Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020)
Table 88. Europe Coagulation Factor Concentrates Sales by Countries (2015-2020) (K Pcs)
Table 89. Europe Coagulation Factor Concentrates Sales Market Share by Countries (2015-2020)
Table 90. Europe Coagulation Factor Concentrates Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Coagulation Factor Concentrates Sales by Regions (2015-2020) (K Pcs)
Table 92. Asia-Pacific Coagulation Factor Concentrates Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Coagulation Factor Concentrates Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Coagulation Factor Concentrates Sales by Countries (2015-2020) (K Pcs)
Table 95. South America Coagulation Factor Concentrates Sales Market Share by Countries (2015-2020)
Table 96. South America Coagulation Factor Concentrates Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Coagulation Factor Concentrates Sales by Countries (2015-2020) (K Pcs)
Table 99. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Coagulation Factor Concentrates Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020)
Table 102. Global Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 103. Global Coagulation Factor Concentrates Sales Share by Type (2015-2020)
Table 104. Global Coagulation Factor Concentrates Revenue by Type (2015-2020) (USD Million)
Table 105. Global Coagulation Factor Concentrates Revenue Share by Type (2015-2020)
Table 106. Global Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 107. Global Coagulation Factor Concentrates Sales Share by Application (2015-2020)
Table 108. Global Coagulation Factor Concentrates Sales Forecast by Regions (2021-2025) (K Pcs)
Table 109. Global Coagulation Factor Concentrates Market Share Forecast by Regions (2021-2025)
Table 110. Global Coagulation Factor Concentrates Sales Forecast by Type (2021-2025) (K Pcs)
Table 111. Global Coagulation Factor Concentrates Market Share Forecast by Type (2021-2025)
Table 112. Global Coagulation Factor Concentrates Sales Forecast by Application (2021-2025)
Table 113. Global Coagulation Factor Concentrates Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Coagulation Factor Concentrates Picture
Figure 2. Global Sales Market Share of Coagulation Factor Concentrates by Type in 2019
Figure 3. Factor VIII Picture
Figure 4. Factor IX Picture
Figure 5. Von Willebrand Factor Picture
Figure 6. Prothrombin Complex Concentrates Picture
Figure 7. Fibrinogen Concentrates Picture
Figure 8. Factor XIII Picture
Figure 9. Coagulation Factor Concentrates Sales Market Share by Application in 2018
Figure 10. Neurology Picture
Figure 11. Immunology Picture
Figure 12. Hematology Picture
Figure 13. Critical Care Picture
Figure 14. Pulmonology Picture
Figure 15. Hemato-Oncology Picture
Figure 16. Rheumatology Picture
Figure 17. Others Picture
Figure 18. Global Coagulation Factor Concentrates Market Status and Outlook (2015-2025) (USD Million)
Figure 19. United States Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Canada Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Mexico Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Germany Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 23. France Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 24. UK Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Russia Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Italy Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 27. China Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Japan Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Korea Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 30. India Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Southeast Asia Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Australia Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 33. Brazil Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Egypt Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Saudi Arabia Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 36. South Africa Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Turkey Coagulation Factor Concentrates Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Global Coagulation Factor Concentrates Sales Market Share by Manufacturer in 2019
Figure 39. Global Coagulation Factor Concentrates Revenue Market Share by Manufacturer in 2019
Figure 40. Top 3 Coagulation Factor Concentrates Manufacturer (Revenue) Market Share in 2019
Figure 41. Top 6 Coagulation Factor Concentrates Manufacturer (Revenue) Market Share in 2019
Figure 42. Key Manufacturer Market Share Trend
Figure 43. Global Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 44. Global Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. Global Coagulation Factor Concentrates Revenue Market Share by Regions (2015-2020)
Figure 46. Global Coagulation Factor Concentrates Revenue Market Share by Regions in 2018
Figure 47. North America Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
Figure 48. Europe Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
Figure 50. South America Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
Figure 51. Middle East & Africa Coagulation Factor Concentrates Sales and Growth Rate (2015-2020)
Figure 52. North America Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. North America Coagulation Factor Concentrates Sales Market Share by Countries (2015-2020)
Figure 54. North America Coagulation Factor Concentrates Sales Market Share by Countries in 2018
Figure 55. North America Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 56. North America Coagulation Factor Concentrates Revenue Market Share by Countries in 2018
Figure 57. United States Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Canada Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Mexico Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Europe Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Europe Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020)
Figure 62. Europe Coagulation Factor Concentrates Revenue Market Share by Countries in 2019
Figure 63. Germany Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. UK Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. France Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Russia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Italy Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Asia-Pacific Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. Asia-Pacific Coagulation Factor Concentrates Sales Market Share by Regions 2019
Figure 70. Asia-Pacific Coagulation Factor Concentrates Revenue Market Share by Regions 2019
Figure 71. China Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Japan Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Korea Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. India Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Southeast Asia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. South America Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. South America Coagulation Factor Concentrates Sales Market Share by Countries in 2019
Figure 78. South America Coagulation Factor Concentrates Revenue Market Share by Countries in 2019
Figure 79. Brazil Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Argentina Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Middle East and Africa Coagulation Factor Concentrates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 82. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Countries in 2019
Figure 83. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Countries (2015-2020)
Figure 84. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Countries in 2019
Figure 85. Saudi Arabia Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Egypt Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Turkey Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 88. South Africa Coagulation Factor Concentrates Sales and Growth Rate (2015-2020) (K Pcs)
Figure 89. Global Coagulation Factor Concentrates Sales and Growth Rate (2021-2025) (K Pcs)
Figure 90. Global Coagulation Factor Concentrates Revenue and Growth Rate (2021-2025) (USD Million)
Figure 91. North America Sales Coagulation Factor Concentrates Market Forecast (2021-2025) (K Pcs)
Figure 92. Europe Sales Coagulation Factor Concentrates Market Forecast (2021-2025) (K Pcs)
Figure 93. Asia-Pacific Sales Coagulation Factor Concentrates Market Forecast (2021-2025) (K Pcs)
Figure 94. South America Sales Coagulation Factor Concentrates Market Forecast (2021-2025) (K Pcs)
Figure 95. Middle East & Africa Sales Coagulation Factor Concentrates Market Forecast (2021-2025) (K Pcs)
Figure 96. Sales Channel: Direct Channel vs Indirect Channel
ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- ヒト凝固第VIII因子の世界市場 2020年 Market Overview The Human Coagulation Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 力率改善（PFC）装置の世界市場 2020年 Market Overview The Power Factor Correction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 上皮成長因子（EGF）の世界市場 2020年 Market Overview The Epidermal Growth Factor (EGF) (CAS 62253-63-8) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
- グリア細胞株由来神経栄養因子の世界市場 2020年 Market Overview The global Glial Cell Line Derived Neurotrophic Factor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The G…